Peter Marks, M.D., Ph.D. is the director of the Center for Biologics Evaluation and Research (CBER) at the FDA.
The center is responsible for assuring the safety and effectiveness of biological products, including vaccines, allergenic products, blood and blood products, and cellular, tissue, and gene therapies.